Search - Université de Lyon Access content directly

Filter your results

8 Results
authFullName_s : Christos Chouaid

Association between lung cancer somatic mutations and occupational exposure in never-smokers

Christophe Paris , Pascal Do , Bénédicte Mastroianni , Adrien Dixmier , Patrick Dumont , et al.
European Respiratory Journal, 2017, 50 (4), pp.1700716. ⟨10.1183/13993003.00716-2017⟩
Journal articles hal-01647080v1

Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study

L. Laforest , Nicolas Roche , Gilles Devouassoux , Manon Belhassen , Christos Chouaid , et al.
Respiratory Medicine, 2016, 117, pp.33--39. ⟨10.1016/j.rmed.2016.05.019⟩
Journal articles hal-01838973v1

Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial

Jaafar Bennouna , Nicolas Girard , Clarisse Audigier-Valette , Aurélie Le Thuaut , Radj Gervais , et al.
Clinical Lung Cancer, 2020, 21 (1), pp.e10-e14. ⟨10.1016/j.cllc.2019.09.007⟩
Journal articles hal-02504807v1

[Cost-effectiveness of darbepoetin alpha in an every-3-weeks schedule].

Isabelle Borget , Christos Chouaid , Nadia Demarteau , Lieven Annemans , Jean-Louis Pujol
Bulletin du Cancer, 2008, 95 (4), pp.465-73. ⟨10.1684/bdc.2008.0623⟩
Journal articles hal-00597071v1
Image document

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

Arnaud Scherpereel , Isabelle Durand-Zaleski , François-Emery Cotté , Jérôme Fernandes , Didier Debieuvre , et al.
BMC Cancer, 2018, 18, pp.1013. ⟨10.1186/s12885-018-4958-5⟩
Journal articles hal-01907440v1

Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units

Anne-Claire Toffart , Xavier Dhalluin , Nicolas Girard , Christos Chouaid , Clarisse Audigier-Valette , et al.
Intensive Care Medicine, 2015, 41 (1), pp.164-165. ⟨10.1007/s00134-014-3535-x⟩
Journal articles hal-02637257v1
Image document

Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy

Faustine Dalon , Gilles Devouassoux , Manon Belhassen , Gaëlle Nachbaur , Camille Correia da Silva , et al.
International Journal of Chronic Obstructive Pulmonary Disease, 2019, Volume14, pp.2905 - 2915. ⟨10.2147/copd.s222762⟩
Journal articles hal-04143437v1
Image document

Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018

Olivier Bylicki , Pascale Tomasini , Gervais Radj , Florian Guisier , Isabelle Monnet , et al.
European Journal of Cancer, 2023, 183, pp.38-48. ⟨10.1016/j.ejca.2023.01.014⟩
Journal articles hal-04016683v1